Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables and no. of employees. Unidades: specified in variables Fewer than 250 employees 250 or more employees Total No. of companies carrying out R&D in Biotechnology 975 81 1.056 %Companies according to biotechnology used: Genetic code 35 46 36 %Companies according to biotechnology used: Functional units 44 50 45 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 26 45 27 %Companies according to biotechnology used: Bioprocesses 45 66 47 %Companies according to biotechnology used: Sub-cellular organisms 8 15 8 %Companies according to biotechnology used: Bio-computing 24 32 25 %Companies according to biotechnology used: Nanobiotechnology 13 16 13 %Companies according to biotechnology used: Other 15 13 15 Companies in which biotechnology activities are: Main and/or exclusive 538 12 551 Companies in which biotechnology activities are: A secondary line of business 164 19 183 Companies in which biotechnology activities are: A tool necessary for production 273 50 323 %Company by field(s) of ultimate application of biotechnology use: Human Health 49 52 49 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 22 3 20 %Company by field(s) of ultimate application of biotechnology use: Food products 30 36 30 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 23 13 23 %Company by field(s) of ultimate application of biotechnology use: Environment 13 17 13 %Company by field(s) of ultimate application of biotechnology use: Industry 13 7 12 Personnel in R&D in biotechnology (no. of persons) 7.908 2.811 10.719 Personnel in R&D in biotechnology (no. of persons): Researchers 4.660 1.470 6.131 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 3.247 1.341 4.588 Personnel in R&D in biotechnology (no. of persons): women 4.291 1.749 6.040 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.520 891 3.411 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 1.772 857 2.629 Personnel in R&D in biotechnology (FTE) 5.651,3 2.099,5 7.750,8 Personnel in R&D in biotechnology (FTE): Researchers 3.461,8 1.056,3 4.518,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.189,4 1.043,3 3.232,7 Personnel in R&D in biotechnology (FTE): women 3.133,9 1.337,5 4.471,4 Personnel in R&D in biotechnology (FTE): (women) Researchers 1.912 650,7 2.562,7 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.221,9 686,8 1.908,7 Internal expenditure on R&D (thousands of euros) 511.004 168.555 679.558 1) By nature of the expense: Current expenses 470.651 163.981 634.631 1.1) Remuneration to researchers 167.208 61.649 228.857 1.2) Remuneration to technicians and assistants 63.658 40.840 104.498 1.3) Other current expenses 239.785 61.492 301.276 2) By nature of the expense: Capital expenses 40.353 4.574 44.927 2.1) Land and buildings 2.519 66 2.585 2.2) Equipment and instruments 19.828 3.741 23.569 2.3) Acquisition of specific R&D software 780 612 1.392 2.4) Otros productos de propiedad intelectual específicos para I+D 17.226 155 17.381 1) By origin of the funds: National funds 417.983 138.313 556.297 1.1) Own funds 301.946 85.064 387.010 1.2) From companies 49.801 36.223 86.025 1.3) Public Administration funds 61.218 13.546 74.764 1.4) From Universities 408 0 408 1.5) From non profit private institutions 4.610 3.480 8.090 1) By origin of the funds: Foreign funds 93.020 30.241 123.262 2.1) From EU programmes 18.993 6.132 25.125 2.2) Other foreign funds 74.027 24.109 98.137 Purchase of R&D services in biotechnology (thousands of euros) 86.267 61.292 147.558 Purchase of R&D services in biotechnology (thousands of euros): In Spain 26.503 50.373 76.875 Purchase of R&D services in biotechnology (thousands of euros): Abroad 59.764 10.919 70.683 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 50 25 49 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 14 11 14 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16 15 16 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 13 15 13 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 18 13 18 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 19 8 18 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 17 14 17 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 38 30 37 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 52 40 51 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 18 14 18 % Companies that have requested biotechnology patents in Biotechnology 15 16 16 Number of patents requested 602 144 746 % Companies with income of an international origin related to biotechnological activities 23,9 16 23,3 % Turnover representing income of an international origin related to biotechnological activities 5,7 0,7 1,2 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 49,3 69,7 60,4 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 50,7 30,3 39,6 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 92,6 71,2 80,9 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 5,5 27,9 17,8 % Income of an international origin related with activities according to the classification: Operating source abroad 1,9 0,8 1,3 % Income of an international origin related with activities according to the classification: Other 0,1 . 0,1 Notas: . '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute